Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

about

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

Item

http://www.wikidata.org/entity/Q55153722

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

@en

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

@nl

type

Item

label

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

@en

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

@nl

prefLabel

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

@en

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

@nl

P1476

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

@en

P2093

Aniek Lamberts

http://www.w3.org/2001/XMLSchema#string

Barbara Horváth

http://www.w3.org/2001/XMLSchema#string

H Ilona Euverman

http://www.w3.org/2001/XMLSchema#string

Jorrit B Terra

http://www.w3.org/2001/XMLSchema#string

Marcel F Jonkman

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for bullous pemphigoid

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.

The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

Consensus statement on the use of rituximab in patients with rheumatoid arthritis

P304

248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.00248

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29520266

http://www.w3.org/2001/XMLSchema#string

P932

5827539

http://www.w3.org/2001/XMLSchema#string